Walsh Deina H bought BBLG
January 8, 2026 · Form 4 insider transaction
Walsh Deina H bought 8,335 shares of Bone Biologics Corporation at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 13 days after the transaction.
Direction
Acquired (buy-side)
Shares
8,335
Price
$0.00
Total value
N/A
InsiderWalsh Deina H
Role—
SecurityEmployee Stock Option
Transaction codeA: Grant or award
Transaction dateJanuary 8, 2026
Filing dateJanuary 21, 2026
Shares owned after8,335
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
This option was granted under the Bone Biologics Corporation 2015 Equity Incentive Plan, in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests and becomes exercisable immediately.